Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives

For the full experience visit: Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives

The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew the go-to drug in many cases was Pfizer Inc.’s Ibrance. She learned it might cost her mother, who lived on a fixed income, around $10,000 out of pocket annually.

For the full story please visit: https://www.bloomberg.com/graphics/2025-cancer-treatment-costs/

--With assistance from Jade Khatib, Fiona Rutherford, Damian Garde and Sam Hornblower.

To contact the authors of ...